N
Nancy A. Rigotti
Researcher at Harvard University
Publications - 388
Citations - 25632
Nancy A. Rigotti is an academic researcher from Harvard University. The author has contributed to research in topics: Smoking cessation & Abstinence. The author has an hindex of 75, co-authored 349 publications receiving 20316 citations. Previous affiliations of Nancy A. Rigotti include University of Iowa & Mayo Clinic.
Papers
More filters
Journal ArticleDOI
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study
Gregory A. Roth,George A. Mensah,Catherine O. Johnson,Giovanni Addolorato,Enrico Ammirati,Larry M. Baddour,Noël C. Barengo,Andrea Beaton,Emelia J. Benjamin,Catherine P. Benziger,Aimé Bonny,Michael Brauer,Marianne Brodmann,Thomas J. Cahill,Jonathan R. Carapetis,Alberico L. Catapano,Sumeet S. Chugh,Leslie T. Cooper,Josef Coresh,Michael H. Criqui,Nicole K. DeCleene,Kim A. Eagle,Sophia Emmons-Bell,Valery L. Feigin,Joaquim Fernández-Solà,F. Gerry R. Fowkes,Emmanuela Gakidou,Scott M. Grundy,Feng J. He,George Howard,Frank B. Hu,Lesley A. Inker,Ganesan Karthikeyan,Nicholas J Kassebaum,Walter Koroshetz,Carl J. Lavie,Donald M. Lloyd-Jones,Hong Lu,Antonio Mirijello,Awoke Misganaw Temesgen,Ali H. Mokdad,Andrew E. Moran,Paul Muntner,Jagat Narula,Bruce Neal,Mpiko Ntsekhe,Glaucia Moraes de Oliveira,Catherine M Otto,Mayowa O. Owolabi,Michael Pratt,Sanjay Rajagopalan,Marissa B Reitsma,Antonio Luiz Pinho Ribeiro,Nancy A. Rigotti,Anthony Rodgers,Craig Sable,Saate S Shakil,Karen Sliwa-Hahnle,Benjamin A Stark,Johan Sundström,Patrick Timpel,Imad I. Tleyjeh,Marco Valgimigli,Theo Vos,Paul K. Whelton,Magdi H. Yacoub,Liesl Zühlke,Christopher J L Murray,Valentin Fuster +68 more
TL;DR: CVD burden continues its decades-long rise for almost all countries outside high-income countries, and alarmingly, the age-standardized rate of CVD has begun to rise in some locations where it was previously declining in high- income countries.
Journal ArticleDOI
Efficacy of Varenicline, an 42 Nicotinic Acetylcholine Receptor Partial Agonist, vs Placebo or Sustained-Release Bupropion for Smoking Cessation A Randomized Controlled Trial
Douglas E. Jorenby,J. Taylor Hays,Nancy A. Rigotti,Salomon Azoulay,Watsky Eric Jacob,Kathryn E. Williams,Clare B. Billing,Jason Gong,Karen R. Reeves +8 more
TL;DR: Varenicline is an efficacious, safe, and well-tolerated smoking cessation pharmacotherapy and its short-term and long-term efficacy exceeded that of both placebo and bupropion SR.
Journal ArticleDOI
Interventions for smoking cessation in hospitalised patients
TL;DR: There is insufficient direct evidence to conclude that adding NRT or bupropion to intensive counselling increases cessation rates over what is achieved by counselling alone, but the evidence of benefit for NRT has strengthened in this update.
Journal ArticleDOI
Initial symptoms of nicotine dependence in adolescents
Joseph R. DiFranza,Nancy A. Rigotti,Ann McNeill,Judith K. Ockene,Judith A. Savageau,Dorothy M. St. Cyr,Mardia A. Coleman +6 more
TL;DR: The first symptoms of nicotine dependence can appear within days to weeks of the onset of occasional use, often before the onset with respect to the duration and frequency of tobacco use.
Journal ArticleDOI
US college students' use of tobacco products: results of a national survey.
TL;DR: It is indicated that tobacco use is common among college students and is not limited to cigarettes, and national efforts to monitor and reduce tobacco use of all types should expand to focus on collegeStudents and other young adults.